Premium
Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer
Author(s) -
SHIOI KOICHI,
YOSHIDA MINORU,
SAKAI NAOKI
Publication year - 2003
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2003.00705.x
Subject(s) - leuprorelin , bicalutamide , medicine , prostate cancer , urology , interstitial pneumonitis , blockade , oncology , prostate , endocrine system , cancer , androgen receptor , hormone , lung , receptor , respiratory disease , luteinizing hormone , gonadotropin releasing hormone
Maximal androgen blockade therapy is the standard endocrine treatment for advanced prostate cancer. We report here an unusual case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate treatment for metastatic prostate cancer.